About ERN LUNG
Expertise
patients
clinicians
ERN-LUNG Academy

The ERN-LUNG Academy is a curriculum for medical staff at any stage of their career, who wishes to get a proof of knowledge on rare respiratory diseases. It consists of Webinars and eCases, but also includes on-site training in ERN-LUNG Centers. We call for applications from participants of EU-member States from September to November each year. Classes start in January. If you wish to apply for next yearโ€™s class, please send a letter of motivation to info@ern-lung.eu

ERN-LUNG Online advance system

The EXpert Advisory BOard (EXABO) is a pan-European internet platform, which has been developed in the context of ERN-LUNG in liaison with the Medical Informatics Group of University Hospital Frankfurt, to answer questions on all aspects of rare respiratory diseases. The platform is primarily aimed at patients and care team members but is openly accessible by anyone who wants to ask a related question.

NETWORK
News

Conference on Rare Diseases in Warsaw, Poland

The Conference on Rare Diseases in Warsaw, Poland, held on April 10, 2025, was a significant event focused on shaping a European Action Plan on Rare Diseases. Organized by the European Economic and Social Committee (EESC), the Polish Ministry of Health, and the Medical University of Warsaw, the conference aimed to strengthen European-national cooperation and improve policies for rare disease patients. The conference brought together policymakers, researchers, clinicians, and patient advocates to pave the way for the rare disease community.
Key discussions included:

  • Developing a European policy framework to complement existing legislation and promote investment.
  • Enhancing cooperation at EU and national levels to improve diagnosis and treatment.
  • Advocating for a comprehensive European Action Plan with clear, measurable objectives.
  • Bridging research and patient care, with a dedicated side-event on April 11, 2025, for clinicians, researchers, and patients.

The conference was held under the Polish Presidency of the EU Council, emphasizing the urgency of reducing diagnosis time and ensuring better access to genetic diagnostics and therapies.